Add like
Add dislike
Add to saved papers

Nanotubular Iridium-Cobalt Mixed Oxide Crystalline Architectures Inherited from Cobalt Oxide for Highly Efficient Oxygen Evolution Reaction Catalysis.

Here, we report the unique transformation of one-dimensional tubular mixed oxide nanocomposites of iridium (Ir) and cobalt (Co) denoted as Irx Co1-x Oy , where x is the relative Ir atomic content to the overall metal content. The formation of a variety of Irx Co1-x Oy (0 ≤ x ≤ 1) crystalline tubular nanocomposites was readily achieved by electrospinning and subsequent calcination process. Structural characterization clearly confirmed that Irx Co1-x Oy polycrystalline nanocomposites had a tubular morphology consisting of Ir/IrO2 and Co3 O4 , where Ir, Co, and O were homogeneously distributed throughout the entire nanostructures. The facile formation of Irx Co1-x Oy nanotubes was mainly ascribed to the inclination of Co3 O4 to form the nanotubes during the calcination process, which could play a critical role in providing a template of tubular structure and facilitating the formation of IrO2 by being incorporated with Ir precursors. Furthermore, the electroactivity of obtained Irx Co1-x Oy nanotubes was characterized for oxygen evolution reaction (OER) with rotating disk electrode voltammetry in 1 M NaOH aqueous solution. Among diverse Irx Co1-x Oy , Ir0.46 Co0.54 Oy nanotubes showed the best OER activity (the least-positive onset potential, greatest current density, and low Tafel slope), which was even better than that of commercial Ir/C. The Ir0.46 Co0.54 Oy nanotubes also exhibited a high stability in alkaline electrolyte. Expensive Ir mixed with cheap Co at an optimum ratio showed a greater OER catalytic activity than pure Ir oxide, one of the most efficient OER catalysts.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app